In this review it is necessary to understand the capacities of the pharmaceutical industry to meet the new challenges arising from the TRIPS Agreement. In past, pharmaceutical industry did not face any rigours of strong patent systems. The new situation is going to be totally different. This article will give brief review on pharmaceutical market of India, Indonesia, Sri Lanka and a co-relation between the pharmaceutical policy and the patent laws has to be established to the maximum extent so that the industry is able to play its role adequately to facilitate easy access to medicines at competitive prices. Rising research and development (R&D) expenditures by pharmaceutical industries are, in part, a consequence of changing industry structure, notably the increase of the biotechnology sector.
Loading....